Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-016106

Chief Financial Officer gave up 352 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Hamm John M. · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-11-27 Shares withheld for taxes : show line 1 in the form −352 $1.67 $588 26,448 D
Loading xslF345X05/marketforms-63729.xml…